(Q33410858)

26 July 2017

Hypermethylation of genes for diagnosis and risk stratification of prostate cancer (English)

1 reference

26 July 2017

1 reference

1 reference

Mathias Ehrich

2

0 references

author name string

Donkena Krishna Vanaja

1

1 reference

26 July 2017

Dirk Van den Boom

3

1 reference

26 July 2017

John C Cheville

4

1 reference

26 July 2017

R Jeffrey Karnes

5

1 reference

26 July 2017

Donald J Tindall

6

1 reference

26 July 2017

Charles R Cantor

7

1 reference

26 July 2017

Charles Y F Young

8

1 reference

26 July 2017

1 June 2009

1 reference

26 July 2017

1 reference

26 July 2017

27

1 reference

26 July 2017

5

1 reference

26 July 2017

549-560

1 reference

Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

DNA methyltransferase inhibitors for cancer therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

The epigenomics of cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

The cancer epigenome--components and functional correlates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Epigenetic therapy of cancer: past, present and future

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Gene promoter methylation in prostate tumor-associated stromal cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Epigenetic changes in prostate cancer: implication for diagnosis and treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Molecular detection of prostate cancer: a role for GSTP1 hypermethylation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Epigenetics in human disease and prospects for epigenetic therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Epigenetics and cancer: implications for drug discovery and safety assessment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Simultaneous gene clustering and subset selection for sample classification via MDL.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

The power and the promise of DNA methylation markers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

MethPrimer: designing primers for methylation PCRs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Diagnosis of multiple cancer types by shrunken centroids of gene expression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Delineation of prognostic biomarkers in prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Dot far-western blot analysis of relative binding affinities of the Src homology 3 domains of Efs and its related proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

CpG islands in vertebrate genomes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693083

Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer

21 June 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Multigene methylation analysis for detection and staging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Hypermethylation of CpG islands in primary and metastatic human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Retinoic acid receptor beta2 hypermethylation: implications for prostate cancer detection, prevention, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

[GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

A quantitative promoter methylation profile of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaborati

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802620794

Gene expression correlates of clinical prostate cancer behavior

21 January 2018

1 reference

12 December 2020

Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors

1 reference

12 December 2020

Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy

1 reference

12 December 2020

New markers may help predict prostate cancer relapse risk

1 reference

12 December 2020

Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy

1 reference

12 December 2020

Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers

1 reference

12 December 2020

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy

1 reference

12 December 2020

Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy

1 reference

12 December 2020

The impact of definitions of failure on the interpretation of biochemical recurrence following treatment of clinically localized prostate cancer

1 reference

12 December 2020

Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

1 reference

12 December 2020

10.1080/07357900802620794

Identifiers

DOI

1 reference

release_te2lyvu2grh7lfalyvpckjdksm

26 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/te2lyvu2grh7lfalyvpckjdksm

24 November 2022

mapped directly with Wikidata item

PMCID

2693083

1 reference

26 July 2017

1 reference